Angiotensinogen, Human Plasma
Catalogue Number: 16-16-011407-ART
16-16-011407 Image
16-16-011407 Image
SDS-PAGE: 4-12% Bis-Tris NuPAGE gel 1. AGT - 5 µg (reduced / heated) 2. AGT - 10 µg (reduced / heated) 3. AGT - 20 µg (reduced / heated) 4. LMW Standard (BIO-RAD Cat. No. 161-0304) 5. Empty 6. AGT - 5 µg (non-reduced / no heat) 7. AGT - 10 µg (non-reduced / no heat) 8. AGT - 20 µg (non-reduced / no heat)
| Manufacturer: | Athens Research |
| Preservative: | Lyophilized from 30 mM sodium phosphate, pH 6.8 |
| Molecular Weight: | 55,000-65,000 Da |
| Ph: | ph 6.8 |
| Physical state: | Lyophilized |
| Type: | Other Proteins |
| Shipping Condition: | Blue Ice |
| Unit(s): | 100 ug |
Description
Description: Angiotensinogen (AGT) is a glycoprotein found in plasma at a concentration of 2.8-7.1 mg per 100mL in healthy individuals. AGT is produced primarily by the liver but also is synthesized in the brain, large arteries, kidneys and adipose tissue. In plasma it exists as a monomeric form (55-65 kDa) as well as a high molecular mass form (200-550 kDa). In non-pregnant individuals with normal blood pressure, the high molecular mass form accounts for 3% of total circulating AGT. In the first half of pregnancy the total AGT increases by 4-fold and the high molecular mass form increases by 20-fold. Up to 80% of the total AGT in amniotic fluid is the high molecular mass form.
16-16-011407 Datasheet
SUPPORT
outstanding technical support
PRODUCT
we offer a full product guarantee
DELIVERY
we offer free delivery to UK universities and non profit organisations